EGFR and non-small cell lung carcinoma: Hu et al., to address a better understanding of CAFs in NSCLC, established patient-derived fibroblasts (PDF) from NSCLC biopsies with specific oncogenic alterations such as EGFR mutations or anaplastic large-cell lymphoma kinase (ALK) fusions.